Clinical Trial Update: A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy [Phase 4]

View source ↗

Summary

A completed Phase 4 double-blind, placebo-controlled trial evaluating the effects of rasagiline on cognition in Parkinson's disease patients receiving dopaminer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: Georgetown University | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED